PA
NKLR

PharVision Advisers’s Terra Innovatum Global N.V. NKLR Stock Holding History

PharVision Advisers’s Portfolio NKLR Stock Details NKLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,852
Closed -$119K – 705
2025
Q4 		$119K Buy
+25,852
New +$181K 0.06% 641

Other funds holding NKLR

ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $14.1B AUM 25.71% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
VCM
Vennlight Capital Management Weston, Connecticut $99M AUM 77.4% 1-Year Est. Return
HCC
Hatch Cove Capital Chicago, Illinois $225M AUM
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

PharVision Advisers's NKLR Position: Q1 2026 in Review

PharVision Advisers sold out of Terra Innovatum Global N.V. (NKLR) in Q1 2026, closing a stake of 25,852 shares — an estimated $119K sold.

PharVision Advisers first reported a position in NKLR in Q4 2025 and held it in 1 quarter. The position peaked at $119K in Q4 2025. 38 funds tracked by Wall St. Rank hold NKLR as of Q1 2026.

  • PharVision Advisers reported no remaining Terra Innovatum Global N.V. position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 25,852 Terra Innovatum Global N.V. shares in Q1 2026, an estimated $119K.
  • PharVision Advisers first reported a position in Terra Innovatum Global N.V. in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Terra Innovatum Global N.V. position peaked at $119K in Q4 2025.
  • 38 funds tracked by Wall St. Rank held Terra Innovatum Global N.V. as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.